NEELI GENETIC SERVICES PVT. LTD. offers a broad range of early-stage detection and Personalized treatment of cancer disease services principally to the medical experts and health care industry. The company focuses on establishing strategic alliance and collaboration to offer its services. Neeli Genetic Services entered into agreements with RGCC International GmBH, a leading company in analysis of Circulating tumor cells as well as Cancer Stem Cells. The services aim to evaluate a new technology to isolate and measure all types of suspended cancer cells, including Circulating Tumor Cells(CTCs), from blood, and thus pave the way for better cancer treatments. Cancer with tumors that metastasize, i.e. cancer that forms secondary tumors in the body, is very difficult to cure if not discovered early. An early sign of metastasis is an increased level of CTC, Circulating Tumor Cells, in the blood. RGCC uses, patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments.
Posted on: Fri, 26 Dec 2014 15:02:53 +0000
Trending Topics
Recently Viewed Topics
© 2015